Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review.
Mohammad A, Yurina A, Simonyan T, Chistyakov D, Salman R, Zornikova K, Minina E, Bogolyubova A. Mohammad A, et al. Among authors: zornikova k. Front Immunol. 2024 Dec 6;15:1409665. doi: 10.3389/fimmu.2024.1409665. eCollection 2024. Front Immunol. 2024. PMID: 39712013 Free PMC article.
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Horwitz SM, Nirmal AJ, Rahman J, Xu R, Drill E, Galasso N, Ganesan N, Davey T, Hancock H, Perez L, Maccaro C, Bahgat A, Marzouk E, Cathcart E, Moskowitz A, Noy A, Kumar A, Jacobsen E, Fisher DC, Mehta-Shah N, Kim YH, Khodadoust M, Kotlov N, Nikitina A, Kudryashova O, Zubareva V, Zornikova K, Shin N, Sorokina M, Degryse S, Postovalova E, Bagaev A, Hosszu K, McAvoy D, Boelens JJ, Wu W, Ciantra Z, Appelt JW, Trevisani C, Amaka S, Weinstock DM, Vardhana SA. Horwitz SM, et al. Among authors: zornikova k. Nat Med. 2024 Dec;30(12):3778. doi: 10.1038/s41591-024-03404-w. Nat Med. 2024. PMID: 39548313 No abstract available.
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Horwitz SM, Nirmal AJ, Rahman J, Xu R, Drill E, Galasso N, Ganesan N, Davey T, Hancock H, Perez L, Maccaro C, Bahgat A, Marzouk E, Cathcart E, Moskowitz A, Noy A, Kumar A, Jacobsen E, Fisher DC, Mehta-Shah N, Kim YH, Khodadoust M, Kotlov N, Nikitina A, Kudryashova O, Zubareva V, Zornikova K, Shin N, Sorokina M, Degryse S, Postovalova E, Bagaev A, Hosszu K, McAvoy D, Boelens JJ, Wu W, Ciantra Z, Appelt JW, Trevisani C, Amaka S, Weinstock DM, Vardhana SA. Horwitz SM, et al. Among authors: zornikova k. Nat Med. 2024 Sep;30(9):2517-2527. doi: 10.1038/s41591-024-03076-6. Epub 2024 Jun 17. Nat Med. 2024. PMID: 38886623 Clinical Trial.
Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein.
Sheetikov SA, Khmelevskaya AA, Zornikova KV, Zvyagin IV, Shomuradova AS, Serdyuk YV, Shakirova NT, Peshkova IO, Titov A, Romaniuk DS, Shagina IA, Chudakov DM, Kiryukhin DO, Shcherbakova OV, Khamaganova EG, Dzutseva V, Afanasiev A, Bogolyubova AV, Efimov GA. Sheetikov SA, et al. Among authors: zornikova kv. Front Immunol. 2024 Apr 2;15:1369436. doi: 10.3389/fimmu.2024.1369436. eCollection 2024. Front Immunol. 2024. PMID: 38629062 Free PMC article.
rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4+ T Cells via Disruption of c-Myb Binding.
Uvarova AN, Stasevich EM, Ustiugova AS, Mitkin NA, Zheremyan EA, Sheetikov SA, Zornikova KV, Bogolyubova AV, Rubtsov MA, Kulakovskiy IV, Kuprash DV, Korneev KV, Schwartz AM. Uvarova AN, et al. Among authors: zornikova kv. Int J Mol Sci. 2023 Sep 7;24(18):13790. doi: 10.3390/ijms241813790. Int J Mol Sci. 2023. PMID: 37762093 Free PMC article.
Architecture of the SARS-CoV-2-specific T cell repertoire.
Zornikova KV, Sheetikov SA, Rusinov AY, Iskhakov RN, Bogolyubova AV. Zornikova KV, et al. Front Immunol. 2023 Mar 20;14:1070077. doi: 10.3389/fimmu.2023.1070077. eCollection 2023. Front Immunol. 2023. PMID: 37020560 Free PMC article. Review.
Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells.
Pilunov A, Romaniuk DS, Shmelev A, Sheetikov S, Gabashvili AN, Khmelevskaya A, Dianov D, Zornikova K, Shakirova NT, Vagida M, Bogolyubova A, Efimov GA. Pilunov A, et al. Among authors: zornikova k. Cancers (Basel). 2023 Mar 3;15(5):1592. doi: 10.3390/cancers15051592. Cancers (Basel). 2023. PMID: 36900382 Free PMC article.
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia.
Lioznov D, Amosova I, Sheetikov SA, Zornikova KV, Serdyuk Y, Efimov GA, Tsyferov M, Khmelevskii M, Afanasiev A, Khomyakova N, Zubkov D, Tikhonov A, Zhu T, Barreto L, Dzutseva V. Lioznov D, et al. Among authors: zornikova kv. PLoS One. 2023 Mar 8;18(3):e0278878. doi: 10.1371/journal.pone.0278878. eCollection 2023. PLoS One. 2023. PMID: 36888640 Free PMC article. Clinical Trial.
16 results